Alzheimer’s APOE4 Genetic Risk Targeted in Promising Trial

Preliminary results offer hope that gene therapy can protect people with a version of the brain disease driven by a particular gene variant.

GINA KOLATA
Author: GINA KOLATA

Advertisements
{ "slotId": "6845006044", "unitType": "responsive", "resize": "auto" }

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.